187 related articles for article (PubMed ID: 30844422)
1. Direct and simultaneous determination of intra-liposomal and external sulfate in liposomal doxorubicin formulations by capillary electrophoresis/inductively coupled plasma-tandem mass spectrometry (CE/ICP-MS/MS).
Ansar SM; Mudalige T
Int J Pharm; 2019 Apr; 561():283-288. PubMed ID: 30844422
[TBL] [Abstract][Full Text] [Related]
2. Investigation of a liposomal oxaliplatin drug formulation by capillary electrophoresis hyphenated to inductively coupled plasma mass spectrometry (CE-ICP-MS).
Nguyen TT; Østergaard J; Stürup S; Gammelgaard B
Anal Bioanal Chem; 2012 Feb; 402(6):2131-9. PubMed ID: 22245979
[TBL] [Abstract][Full Text] [Related]
3. Determination of platinum drug release and liposome stability in human plasma by CE-ICP-MS.
Nguyen TT; Ostergaard J; Stürup S; Gammelgaard B
Int J Pharm; 2013 Jun; 449(1-2):95-102. PubMed ID: 23583709
[TBL] [Abstract][Full Text] [Related]
4. Direct quantification of unencapsulated doxorubicin in liposomal doxorubicin formulations using capillary electrophoresis.
Ansar SM; Jiang W; Mudalige T
Int J Pharm; 2018 Oct; 549(1-2):109-114. PubMed ID: 29981410
[TBL] [Abstract][Full Text] [Related]
5. Metallomics in drug development: characterization of a liposomal cisplatin drug formulation in human plasma by CE-ICP-MS.
Nguyen TT; Østergaard J; Stürup S; Gammelgaard B
Anal Bioanal Chem; 2013 Feb; 405(6):1845-54. PubMed ID: 23052859
[TBL] [Abstract][Full Text] [Related]
6. Determination of non-liposomal and liposomal doxorubicin in plasma by LC-MS/MS coupled with an effective solid phase extraction: In comparison with ultrafiltration technique and application to a pharmacokinetic study.
Xie Y; Shao N; Jin Y; Zhang L; Jiang H; Xiong N; Su F; Xu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():149-160. PubMed ID: 29175695
[TBL] [Abstract][Full Text] [Related]
7. Characterization of doxorubicin liposomal formulations for size-based distribution of drug and excipients using asymmetric-flow field-flow fractionation (AF4) and liquid chromatography-mass spectrometry (LC-MS).
Ansar SM; Mudalige T
Int J Pharm; 2020 Jan; 574():118906. PubMed ID: 31805309
[TBL] [Abstract][Full Text] [Related]
8. Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations.
Luo R; Li Y; He M; Zhang H; Yuan H; Johnson M; Palmisano M; Zhou S; Sun D
Int J Pharm; 2017 Mar; 519(1-2):1-10. PubMed ID: 28063903
[TBL] [Abstract][Full Text] [Related]
9. Liposomal doxorubicin and free doxorubicin in vivo quantitation method developed on CE-LIF and its application in pharmacokinetic analysis.
Tie C; Jiang X; Zhu C; Wu C
Electrophoresis; 2023 Sep; 44(17-18):1361-1368. PubMed ID: 37578082
[TBL] [Abstract][Full Text] [Related]
10. Direct quantitation of free, encapsulated, total doxorubicin and doxorubicinol in stabilized frozen human plasma to support a BE study of liposomal doxorubicin.
Ji Y; Zhang X; Liu J; Chen Y; Meng M; Li C; Wang L
J Pharm Biomed Anal; 2020 Sep; 189():113388. PubMed ID: 32663760
[TBL] [Abstract][Full Text] [Related]
11. An Automated Capillary Electrophoresis Based Method for Drug Release Profiling of Liposomal Doxorubicin.
Jayaraj S; Jiang W; Mudalige T
J Pharm Sci; 2024 Apr; 113(4):1088-1093. PubMed ID: 38135054
[TBL] [Abstract][Full Text] [Related]
12. Ion quantification in liposomal drug products using high performance liquid chromatography.
Wu J; Crist RM; McNeil SE; Clogston JD
J Pharm Biomed Anal; 2019 Feb; 165():41-46. PubMed ID: 30502551
[TBL] [Abstract][Full Text] [Related]
13. [Determination of trace sulfate ion in liposome doxorubicin with capillary electrophoresis].
Zhan X; Zhu Z; Kang J
Se Pu; 2011 Apr; 29(4):362-4. PubMed ID: 21770249
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous analysis of liposomal doxorubicin and doxorubicin using capillary electrophoresis and laser induced fluorescence.
Kim HS; Wainer IW
J Pharm Biomed Anal; 2010 Jul; 52(3):372-6. PubMed ID: 19625153
[TBL] [Abstract][Full Text] [Related]
15. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer.
Charrois GJ; Allen TM
Biochim Biophys Acta; 2004 May; 1663(1-2):167-77. PubMed ID: 15157619
[TBL] [Abstract][Full Text] [Related]
16. Quantification of pegylated liposomal doxorubicin and doxorubicinol in rat plasma by liquid chromatography/electrospray tandem mass spectroscopy: Application to preclinical pharmacokinetic studies.
Liu Y; Yang Y; Liu X; Jiang T
Talanta; 2008 Jan; 74(4):887-95. PubMed ID: 18371724
[TBL] [Abstract][Full Text] [Related]
17. An Automated Electroanalytical Method for the Drug Release Profiling of Liposomal Doxorubicin HCl Formulations.
Yurtsever F; Jiang W; Mudalige T
J Pharm Sci; 2024 Mar; 113(3):791-797. PubMed ID: 38072115
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?
Mamidi RN; Weng S; Stellar S; Wang C; Yu N; Huang T; Tonelli AP; Kelley MF; Angiuoli A; Fung MC
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1173-84. PubMed ID: 20661737
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: encapsulation and leakage.
Franzen U; Nguyen TT; Vermehren C; Gammelgaard B; Ostergaard J
J Pharm Biomed Anal; 2011 Apr; 55(1):16-22. PubMed ID: 21282028
[TBL] [Abstract][Full Text] [Related]
20. A simple and rapid measurement method of encapsulation efficiency of doxorubicin loaded liposomes by direct injection of the liposomal suspension to liquid chromatography.
Yamamoto E; Miyazaki S; Aoyama C; Kato M
Int J Pharm; 2018 Jan; 536(1):21-28. PubMed ID: 29175642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
